MI/26/48 – Flow Cytometry Technician

Key Details

Job ID:
MI/26/48
Role:
Flow Cytometry Technician
Salary:
£25,500 – £38,076 per annum (dependent upon experience)
Closing date:
7th October 2026

About the role

We are currently looking for a Flow Cytometry Technician within the Flow Cytometry Facility in the rapidly developing field of flow and mass cytometry.

The Facility is equipped with state-of-the-art fluorescent based technology for sorting (Thermo Bigfoot, Sony FP7000, BD Aria, and BD Melody) and analysis (Sony ID7000, BD Fortessa and LSR, Agilent Novocytes and Cytek Imagestream) along with mass cytometry (CyTOF XT) providing an exciting and innovative research and training environment at the leading edge of cell functional analysis and phenotyping.

Your main duty will be, as part of a team, to provide a cell sorting service with additional duties supporting the analysis service and offering front line user support. This is a great opportunity for someone who wishes to develop their experience and skills in the field of flow cytometry technology by developing phenotypic platforms in the cancer research field.

About you

You should have a relevant degree (or equivalent) or significant relevant experience. In addition, you will have relevant experience working in a research or analytical laboratory setting along with experience of working with flow cytometers to exacting quality control standards.  Previous experience in flow cytometry techniques and/or relevant work experience in Life Science Laboratory is essential.

Paterson Building Scientific Administration

More information

Antonia Banyard

Antonia Banyard is the Head of Mass and Flow cytometry at Cancer Research UK Manchester Institute, responsible for line managing the team and supporting research projects across the Institute with staff training and development of new experimental processes

Mass and Flow Cytometry

The Mass and Flow Cytometry Facility provides expertise in fluorescently activated cell sorting (FACS), fluorescent cell analysis (cytometry) fluorescent imaging (imaging cytometry) and mass cytometry (CyTOF) performed on state of the art technology platforms. This includes automation to achieve more efficient and robust datasets which is essential with complex antibody panels.

About CRUK Manchester Institute

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK, the largest independent cancer research organisation in the world. We are situated in Withington, Manchester, next to The Christie NHS Foundation Trust (www.christie.nhs.uk), in South Manchester. with good transport links into the city centre.rnrnWe are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.rnrnOur aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. The Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

Antonia Banyard
Mass and Flow Cytometry
About CRUK Manchester Institute

How to apply?

To apply for this position please complete the online application via ‘Apply Now’. Please ensure you detail the names of two referees and ensure you submit your application before 07 October 2026 Wednesday.

For any informal enquiries about this post, please contact Toni Banyard: antonia.banyard@cruk.manchester.ac.uk

Pease note this vacancy will close for applications at 18:00 hours on the closing date specified.

For any informal enquiries about this Flow Cytometry Technician role, please use this form

Enter your full name
Enter your email address
Type your question here

Why choose Cancer Research UK Manchester Institute?

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org),
the largest independent cancer research organisation in the world.

We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe, which is located adjacent to the CRUK MI Manchester Institute in South Manchester. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Images of stained cells superimposed with headshot images of Samra Turajlic and Tim Somervaille
Image of skin cancer in ageing humans

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Two Institute Scientists elected to the Academy of Medical Sciences

We celebrate the recognition Professor Samra Turajlic and Professor Tim Somervaille by a prestigious medical science institution

New publication: Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

Research explores the role of lipid signalling in cancer behaviour

Cancer Research In the Paterson Building
Two Institute Scientists elected to the Academy of Medical Sciences
New publication: Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion